Diagnostic Prediction Model for De Novo Metastatic Breast Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this observational study is to create a tool to estimate the risk of macroscopic distant tumor spread in women with newly diagnosed breast cancer. The main question it aims to answer is: • Can a model, which combines routine medical information collected at diagnosis, accurately predict if a patient has metastasis large enough to be found during systemic imaging? Researchers will review the past medical records of participants who were treated at a university hospital. Because this study looks at past data, participants will not be asked to do any new tasks, take new tests, or change their medical care.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobieta w wieku 18 lat lub więcej
- •Świeżo zdiagnozowany rak piersi (invasyjny)
- •Przypadek przeanalizowany przez zespół specjalistów w szpitalu podczas okresu badania
- •Brak wcześniejszych nowotworów złośliwych, z wyjątkiem raka w obu piersiach jednocześnie
- •Planowane leczenie w szpitalu prowadzącym badanie
- •Dostęp do pełnej dokumentacji medycznej przez co najmniej 12 miesięcy
✗ Disqualifies
- •Brak badań obrazowych (skanów) wykonanych na początku leczenia
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 12, 2026
- Sex
- Female only
Locations (1)
Markusovszky University Teaching Hospital
Szombathely, Hungary
Trial contact
Oliver L Stari, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/13/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.